We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study.
- Authors
Tatsuno, Ichiro; Kudou, Kentarou; Kagawa, Tomoya
- Abstract
Background Low-density lipoproteins ( LDLs) comprise a heterogeneous group of particles with various size and density. A shift to larger LDL particle size is mainly the result of a decrease in small dense LDL (sd- LDL) levels and an increase in large buoyant LDL (lb- LDL) levels. Methods In a randomized, double-blind study of TAK-085 (containing docosahexaenoic and eicosapentaenoic acid-ethyl esters [ EPA-E]) and an EPA-E product in Japanese patients with hypertriglyceridemia, exploratory evaluations of the effects of the LDL particle size were performed on the basis of LDL-cholesterol/apolipoprotein B ratios and LDL subfractions, which were analyzed with a polyacrylamide gel electrophoresis system. Results Patients were randomized to 12-week treatment with TAK-085 4 g/day (N = 210), TAK-085 2 g/day (N = 205), or EPA-E 1.8 g/day (N = 195). Treatment with TAK-085 4 g/day, TAK-085 2 g/day, and EPA-E 1.8 g/day caused an increase in the LDL cholesterol/apolipoprotein B ratios (3.99%, 3.35%, and 0.66%, respectively), the mean diameter of LDL particles (1.12%, 0.84%, and 0.67%, respectively), and the level of lb- LDL at the end of the study (16.37%, 9.51%, and 7.31%, respectively). The increases in the LDL cholesterol/apolipoprotein B ratios and the mean diameter of LDL particles from baseline to the end of the study were greater with TAK-085 4 g/day than EPA-E 1.8 g/day. TAK-085 4 g/day and TAK-085 2 g/day caused a decrease in the sd- LDL levels (−16.21% and −6.96%, respectively). Conclusion TAK-085 produced a favorable shift in the LDL particle size in Japanese patients with hypertriglyceridemia. JAPIC Clinical Trials Information: Japic CTI-090937.
- Subjects
HYPERTRIGLYCERIDEMIA treatment; DOCOSAHEXAENOIC acid; CARDIOVASCULAR diseases risk factors; EICOSAPENTAENOIC acid; LOW density lipoproteins; THERAPEUTICS
- Publication
Cardiovascular Therapeutics, 2015, Vol 33, Issue 6, p317
- ISSN
1755-5914
- Publication type
Article
- DOI
10.1111/1755-5922.12146